Pomolic acid induces ferroptosis-mediated cell death in non-small cell lung cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pomolic acid (PA) combats non-small cell lung cancer (NSCLC) by inducing ferroptosis, a cell death pathway. This study reveals PA’s molecular mechanisms, offering hope for new NSCLC treatments.
Area Of Science
- Oncology
- Molecular Biology
- Pharmacology
Background
- Pomolic acid (PA) is a bioactive compound from Potentilla freyniana Bornm.
- PA shows palliative use for non-small cell lung cancer (NSCLC) in China.
- The molecular mechanisms of PA's efficacy in NSCLC are not fully understood.
Purpose Of The Study
- To identify the core molecular targets of PA in NSCLC.
- To investigate the functional mechanisms of PA in NSCLC.
- To explore PA's potential as a therapeutic agent for NSCLC.
Main Methods
- Network pharmacology was used to identify PA's targets.
- In vitro studies assessed PA's effects on NSCLC cell death and proliferation.
- Ferroptosis hallmarks (GSH depletion, lipid peroxidation, ROS), protein expression (SLC40A1, SLC7A11, GPX4, ACSL4, HO-1), and mRNA levels (GPX4, SLC7A11, NRF2) were measured.
Main Results
- PA significantly inhibited NSCLC cell proliferation and induced cell death.
- PA triggered ferroptosis, evidenced by GSH depletion, increased lipid peroxidation, and ROS.
- Key ferroptosis regulators showed altered expression: downregulated SLC40A1, SLC7A11, GPX4; upregulated ACSL4, HO-1; reduced mRNA levels of GPX4, SLC7A11, NRF2.
Conclusions
- PA exerts anticancer effects in NSCLC by inducing ferroptosis.
- Modulation of ferroptosis-related proteins and genes supports PA's mechanism of action.
- PA shows promise as a potential therapeutic agent for NSCLC treatment.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...